Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic Estimates 2,400 Patients Eligible For Activa Dystonia Indication

This article was originally published in The Gray Sheet

Executive Summary

Medtronic may pursue full PMA approval of its Activa brain stimulation technology to treat dystonia, upon determining which patients react well to the therapy under a humanitarian device exemption

You may also be interested in...



Deep-Brain Stimulation Effects May Be Based On Structural Change – NEJM

Bilateral deep-brain stimulation (DBS) may effect structural changes in dystonia patients, thereby causing an alleviation of symptoms, according to a study in the Feb. 3 New England Journal of Medicine

Deep-Brain Stimulation Effects May Be Based On Structural Change – NEJM

Bilateral deep-brain stimulation (DBS) may effect structural changes in dystonia patients, thereby causing an alleviation of symptoms, according to a study in the Feb. 3 New England Journal of Medicine

Activa Alternative In Waiting? ANS Taps Deep Brain Stim, Spinal Drug Delivery

Advanced Neuromodulation Systems' deep-brain stimulation device to treat Parkinsonian tremor, nearing pivotal trials, should feature a smaller size and broader programming parameters than Medtronic's Activa DBS, according to the firm

Related Content

UsernamePublicRestriction

Register

MT018245

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel